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Abstract  
 
Leunca (Solanum nigrum L.) has been proven to possess anticancer activity on some 
type of cancer cells. In vitro study of solamargine found in the herb showed cytotoxic effect 
against several breast cancer cell lines, such as T47D and MDA-MB-31. Hence, further study 
on its potential as a co-chemotherapeutic agent needs to be conducted, in order to overcome 
resistance problem commonly found in cancer chemotherapy. This study aimed to examine 
the cytotoxic activity of leunca herb ethanolic extract (LEE) alone and its combination with 
doxorubicin. Single and combinational treatment of LEE and doxorubicin on T47D breast 
cancer cells were done, and their viability representing cytotoxicity were analyzed by using 
MTT assay to determine the IC50 value and combination index (CI) to evaluate the 
combinational effect. Twenty four hours-treatment of LEE alone gave cytotoxicity activity 
showing a dose-dependent manner with the IC50 of 47 µg/ml, while combinational treatment 
showed that 4 µg/ml LEE was found to be synergist with 4 nM doxorubicin on T47D cells, 
with the optimum CI value of 0.59. This result shows that Solanum nigrum L. is potential to be 
proposed as doxorubicin co-chemotherapeutic agent against breast cancer. Further study on 
its molecular mechanism needs to be conducted.  
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INTRODUCTION 
 
Doxorubicin, a chemotherapy agent that is 
applicable for the treatment of several cancer types, 
is widely used in the treatment of breast cancer. 
Medical report by Rumah Sakit Kanker Dharmais 
stated that in 2007 breast cancer shows the highest 
incidence compared to another cancer types 
(Anonym, 2009). The main problems being faced 
in the application of chemotherapeutic agent are its 
toxicity towards normal tissues, suppression of the 
immune system (Wattanapitayakul et al., 2005), 
and occurrence of resistance (Mechetner et al., 
1998). One promising approach to solve this 
problem is the application of co-chemotherapeutic 
agent in cancer therapy. 
Co-chemotherapy may increase 
chemotherapeutic agents’ efficacy, allowing the use 
of lower dosage of chemotherapeutic agent, 
resulting in the decrease of toxicity on normal 
tissues. Potent agent which can be use as co-
chemotherapeutic agent together with doxorubicin 
are phytochemical substances, rendering to the fact 
that there are huge number of substances found in 
plants that are potential against cancer (Gibbs, 
2000), such as solanine, solasodine, and 
solamargine found in leunca (Solanum nigrum L.) 
herb (Everist, 1974; Weller and Phipps, 1979). 
Those steroidal glycosides have been proven to 
possess anticancer activity (Saijo et al., 1982). 
Solamargine as the main constituent being 
responsible for leunca’s anticancer activity (Hu, 
1999) performed cytotoxic activity on several 
cancer cell lines, including T47D and MDA-MB-
231 breast cancer cells. Besides, it also induces 
programmed cell death, apoptosis, through 
mitochondrial pathway (Liang, 2008). Therefore, 
further study on its potential as co-
chemotherapeutic agent needs to be conducted. 
 
 
*Corresponding author e-mail : meiyan_e@ugm.ac.id 
Anandyajati, et al., 2010 
Indones. J. Cancer Chemoprevent., 1(2), 78-84 
 
 
 
79 
 
 
This study aimed to observe the effect of leunca’s 
ethanolic extract (LEE) application to the 
cytotoxicity performed by doxorubicin, analyzed 
by using MTT assay. Combinatorial treatment of 
doxorubicin and LEE were applied in order to 
increase the cytotoxicity of doxorubicin on T47D 
cells, allowing the use of lower dose of the 
chemotherapeutic agent giving less toxicity on 
normal tissues. 
 
METHODS 
 
Sample preparation 
Dried powder of leunca herbs were 
purchased from Balai Besar Penelitian dan 
Pengembangan Tanaman Obat dan Obat 
Tradisional (B2P2TOOT), Indonesia. Dried powder 
was then extracted by maceration for 5 days with 
70% ethanol. Collected filtrate was concentrated 
using rotary evaporator (Heidolph WB2000), then 
dissolved in Dimethyl Sulfoxide (DMSO) (Sigma). 
Both Doxorubicin 5mg/ml and extract solution 
were diluted in DMEM cell culture medium before 
being applied. 
 
Chemicals 
Dulbecco’s Modified Eagle Medium 
(DMEM) powder (Gibco), Fetal Bovine Serum 
(FBS) 10%
v
/v (Gibco), and Penicillin-Streptomycin 
10,000 units/ml penicillin-10,000 μg/ml 
streptomycin (Gibco) were used for cell culture 
medium. Cells were prepared using Tripsin EDTA 
25% (Gibco). For cytotoxicity assay, Sodium 
Dodecyl Sulphate (SDS) 10%
v
/v (Merck) dissolved 
in HCl 0.1N (Merck) as stopper reagent, Phosphate 
Buffer Saline (PBS) pH 7.4 containing KCl (HPLC 
grade, Sigma), NaCl (HPLC grade, Sigma), 
Na2HPO4 (HPLC grade), and KH2PO4 (HPLC 
grade, Sigma) dissolved in aquadest as washing 
reagent, and 3-[4,5-dimethyl thiazole-2-yl(-2,5- 
diphenyltetrazoliumbromide)] (MTT) dissolved in 
PBS as MTT reagent were used. 
 
T47D cells 
T47D cells being used were from the 
collection of Cancer Chemoprevention Research 
Center (CCRC), Universitas Gadjah Mada. The cell 
line was a gift from Prof. Kawaichi, Nara Institute 
of Science and Technology (NAIST), Japan. 
 
Cytotoxicity and combinational assay 
MTT cytotoxicity assay was used to 
examine the effect of LEE alone and in 
combination with doxorubicin on T47D cells. 
T47D cells was distributed to 96-well plate with the 
density of 5x10
3
 cells/well and incubated in 37˚C 
with 5% CO2 for 24 hours. For the cytotoxicity 
assay of LEE on T47D cells alone, LEE was 
applied with the concentration of 1, 10, 50, 100, 
250, 500, and 750 µg/ml to find IC50. In 
combinational assay, concentration of about  
and  IC50 acquired were used for both LEE and 
doxorubicin, giving the concentration of 18, 12, 6, 
and 4 µg/ml for LEE and 6, 4, 2, and 1.5 nM for 
doxorubicin. After 24 hours incubation, MTT 
reagent was applied, followed by 4 hours 
incubation. SDS 10%
v
/v in HCl 0.1N as stopper 
reagent was then applied. Plate was then kept with 
protection from light overnight, continued with 
absorbance determination (λ 595 nm) using ELISA 
reader (Bio-Rad). 
 
Analysis 
Single Cytotoxicity assay 
Linear regression between log concentration 
and % cell viability giving the equation y = Bx + A 
were used to calculate IC50 value, that is the 
concentration inhibiting 50% cell proliferation. 
Combinational Cytotoxicity Assay 
Combinational treatment was evaluated by 
calculating Combination Index (CI) value 
(Reynolds and Maurer, 2005), which has the 
formula as follows. 
 
 
D1 and D2 represent concentrations used in 
combinational treatment, while Dx1 and Dx2 are 
single treatment concentration giving the same 
response as D1 and D2, respectively. CI value 
acquired will allow the evaluation of LEE’s 
potency in combinatorial treatment with 
doxorubicin on T47D cell lines. Interpretation was 
done based on the classification listed in table 1. 
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Table 1. Interpretation of CI value representing potency of combinational application 
 
CI value Interpretation CI Interpretation 
< 0.1 
0.1-0.3 
0.3-0.7 
0.7-0.9 
Very strongly synergist 
Strongly synergist 
Synergist 
Middle synergist 
0.9-1.1 
1.1-1.45 
1.45-3.3 
> 3.3 
Closely additive 
Middle antagonist 
Antagonist 
Strongly antagonist 
 
 
 
RESULTS 
 
Treatment of LEE on T47D cells gave the 
value of cell viability shown in table 2. Increasing 
LEE concentration resulting in the increase of 
cytotoxicity. Linear regression of LEE 
concentration against % cell viability (figure 1) 
gave the IC50 value of 47 µg/ml. Doxorubicin’s 
IC50 on T47D cells is 15 nM (Junedi, 2010). 
Observation of cell morphology after treatment was 
also done, shown in figure 2. Increasing 
concentration of LEE was followed by the 
increasing number of dead cells, quantitatively. 
Both qualitative and quantitative data prove that 
single treatment of LEE on T47D cells showed a 
dose-dependent manner. 
Combinational treatment of LEE and doxorubicin 
on T47D cells gave the CI value shown in table 3, 
and being plotted in diagram (figure 3). It shows 
that 4 concentration combinations, that are 
doxorubicin 
1
/8IC50 – LEE ½ IC50, doxorubicin 
3
/8IC50 – LEE 
1
/8IC50, doxorubicin 
3
/8IC50 – LEE ¼ 
IC50, and doxorubicin 
3
/8IC50 – LEE ½ IC50, 
combination of shows synergicity on T47D cells, 
with CI values less than 0.9. Cell morphology after 
treatment was observed (figure 4). Treatment of 
LEE and doxorubicin alone led to cells’ 
morphological change pointed by black arrows, 
respectively (figure 4(b) and 4(c)). Combination of 
them caused more changes compared to single 
treated cells (figure 4(d)). While control cells 
showed no change in cells’ morphology 
representing cells’ death (figure 4(a)). Hence, 
synergism of combinational treatment was 
observed. 
 
 
 
Table II. % cells viability in single treatment of LEE on T47D cells 
 
LEE concentration (µg/ml) % cell viability 
750 2.33 
500 4.53 
250 9.91 
100 43.94 
50 73.81 
10 76.01 
1 102.57 
 
 
DISCUSSION 
 
This study had observed that treatment of 
LEE on T47D breast cancer cells could inhibit 
cells’ growth with a dose-dependent manner. 
Higher dose of LEE brought less cell viability, 
showing higher toxicity. LEE IC50 value on T47D 
cells of 47 µg/ml was acquired. It represents LEE’s 
efficacy as a single cytotoxic agent. According to 
Ueda, 2000, IC50 value less than 100 µg/ml shows 
that related agent has a potent cytotoxicity. The 
mechanism of cytotoxic activity of solanine and 
solamargine, two steroidal glycosides found in 
leunca herb, had been previously studied. However, 
its specific molecular target has not been 
discovered yet.  
Previous study proved that solamargine and 
solanine could suppress Bcl-2 protein expression 
(Liu et al., 2004; Ji et al., 2008). Bcl-2 functioned 
as antiapoptotic protein that inhibit cells’ death 
Anandyajati, et al., 2010 
Indones. J. Cancer Chemoprevent., 1(2), 78-84 
 
 
 
81 
 
 
through apoptosis, thus its suppression may trigger 
cancer cells’ death (Pandanilam, 2003). Bcl-2 
suppression plays a role in apopotosis induction by 
triggering mitochondrial release of cytochrome c 
which later activates the caspase cascade. Hence, 
one possible mechanism of LEE’s cytotoxic 
activity is by apoptosis induction. Apoptosis may 
occur involving the role of several types of 
proapoptotic proteins, such as Bad, Bax, and Bak 
(Ricci and Zong, 2006). Further study needs to be 
conducted to observe whether or not LEE triggers 
apoptosis and also its ability to affect the 
expression of both proapoptotic and antiapoptotic 
proteins other than Bcl-2 on T47D cells. 
 
 
 
 
 
 Figure 1. Curve of log LEE concentration against % cell viability on T47D cells, showing a dose-dependent 
manner. Linear regression gave the equation y = -37.56x 112.71, giving IC50 value of 47 µg/ml. 
 
 
 
 
Figure 2. T47D cells’ morphology after 24 hours LEE treatment;(a) 1 µg/ml; (b) 10 µg/ml; (c) 50 µg/ml; (d) 
100 µg/ml; (e) 250µg/ml;(f) 500 µg/ml; (g) 750 µg/ml.Higher concentration of LEE caused more 
change in cells’ morphology (round cells being unattached to the well). This phenomenon 
represents a dose-dependent manner. 
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Table III. CI values of combinational treatment of LEE and doxorubicin on T47D cells 
 
 
LEE concentration (µg/ml) 
Doxorubicin (nM) 
1.5 2 4 6 
4 1.54 1.41 0.59 1.83 
6 2.92 2.04 0.81 2.43 
12 0.97 2.05 1.27 1.86 
18 0.79 1.14 0.75 1.31 
 
 
 
Bold numbers shows combination resulting in CI value below 0.9, which are synergist. 
 
 
 
 
 
Figure 3. Diagram of combinational effect of LEE and doxorubicin against CI value. CI value below 0.9 shows 
sinergicity. 
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Figure 4. T47D cells’ morphology after 24 hours treatment; (a) cell control; (b) LEE 4µg/ml; (c) doxorubicin 
4 nM; (d) doxorubicin 4 nM in combination with LEE 4µg/ml. Treatment of LEE and doxorubicin 
alone brought cells to death, shown by change in cells’ morphology pointed by black arrows, 
respectively (figure (b) and (c)). Combination of them caused more cells’ death compared to single 
treated cells (figure (d)), showing sinergicity. While control cells showed no change in cells’ 
morphology representing cells’ death (figure (a)). 
 
 
The efficacy of combination between LEE 
and doxorubicin on T47D cells were analyzed to 
determine their combinational effect, whether they 
are synergist, additive, or antagonistic. It allows us 
to know LEE’s ability to increase 
chemotherapeutics agents’ effectiveness that is 
commonly used in breast cancer therapy. Result 
shows that four combinational doses of doxorubicin 
and LEE performs synergism on their cytotoxicity 
towards T47D cells, meaning that doxorubicin’s 
theraputical dose may be lessen by the application 
of LEE as a cochemotherapeutic agent, giving 
equal effectiveness in inhibiting cancer cells’ 
growth. 
Synergism observed possibly occur because 
of the ability of LEE to strengthen doxorubicin’s 
cytotoxic effect. In this case, doxorubicin is 
cytotoxic towards cells by inhibiting topoisomerase 
II activity (Potter et al., 2002), and was 
strengthened with the cytotoxic activity of solanine 
and solamargine, possibly by triggering apoptosis 
or by inducing cell cycle arrest. Another study is 
required to know the exact mechanism of 
synergism between doxorubicin and LEE. Further 
study on LEE apoptosis induction and its effect on 
related proteins expression need to be conducted in 
order to know more about its cytotoxic molecular 
mechanism.  
 
CONCLUSION  
 
From the study, it can be concluded that 
Solanum nigrum herbs’ ethanolic extract is 
cytotoxic and is able to increase doxorubicin’s 
cytotoxicity on T47D breast cancer cells. 
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